Matt Riley
Vice President, Investor Relations
Replay available
Lucid Diagnostics Inc. (NASDAQ: LUCD) Q2 2026 earnings conference call, held 2026-08-13. Replay captured from the company's public earnings webcast.

Vice President, Investor Relations
Chairman and Chief Executive Officer
Chief Financial Officer
Analyst (on for Kyle Mixon)
Watch the replay and follow the connected company analysis, news, and investor updates for Lucid Diagnostics Inc..
WEBVTT 00:00:00.031 -- 00:00:05.073 Good morning, ladies and gentlemen, and welcome to the Lucid Diagnostics 00:00:05.073 -- 00:00:10.335 Second Quarter 2026 Business Update Conference Call. 00:00:10.335 -- 00:00:13.936 At this time, all lines are in listen-only mode. 00:00:13.936 -- 00:00:19.598 Following the presentation, we will conduct a question and answer session. 00:00:19.598 -- 00:00:24.900 If at any time during this call you require immediate assistance, please press star zero 00:00:24.900 -- 00:00:30.860 for the operator. This call is being recorded on Thursday, August 00:00:30.860 -- 00:00:36.244 13, 2026. I would now like to turn the conference over to Matt Riley, 00:00:36.244 -- 00:00:40.787 Lucid Diagnostics Vice President of Investor Relations. 00:00:40.787 -- 00:00:43.267 Please go ahead. 00:00:43.909 -- 00:00:45.910 Thank you, Operator, and good morning, everyone. 00:00:45.910 -- 00:00:48.672 Thank you for participating in today's business update call. 00:00:48.672 -- 00:00:52.775 Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer 00:00:52.775 -- 00:00:57.487 of Lucid Diagnostics, along with Dennis McGrath, Chief Financial Officer. 00:00:57.487 -- 00:01:00.730 The press release announcing our business update and financial results is available on 00:01:00.730 -- 00:01:04.494 Lushan's website. Please take a moment to read the disclaimers about forward-looking 00:01:04.494 -- 00:01:08.538 statements in the press release. The business update, press release, and conference call 00:01:08.538 -- 00:01:12.002 all include forward-looking statements, and these forward-looking statements are subject 00:01:12.002 -- 00:01:16.687 to known and unknown risks and uncertainties that may cause actual results to differ 00:01:16.687 ...